Catalog Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Tamponade (2226)
|
Event Date 01/29/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
E1.Initial reporter phone: (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation ablation with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced a cardiac tamponade that required pericardial drainage.During positioning before pulmonary vein isolation (pvi), the heartbeat was weak on fluoroscopy.The pericardial effusion was confirmed by intracardiac echocardiography and body surface echocardiography.The pericardial drainage was performed.Timing was after 1 hour of the catheter use.Atrial septal puncture was performed with radio frequency (rf) needle.Cti ablation was performed before pericardial effusion or tamponade was confirmed.Steam pop was not confirmed.Physician assessment of the health hazard was that it was serious.Causal relationship with the product was unknown.Physician's opinion on the relationship between the event and the product was that there was air contamination during the initial puncture (bw products were not used).Possible that the right heart system was injured when the air was removed.No abnormalities observed prior to or during use of product.Additional information was received.The physician¿s opinion on the cause of this adverse event was procedure related.Patient improved.No error messages observed on biosense webster equipment during the procedure.The patient was still in the hospital because another treatment was required in a different department, but did not require extended hospitalization because of the adverse event.
|
|
Manufacturer Narrative
|
It was reported that a patient underwent an atrial fibrillation ablation with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced a cardiac tamponade that required pericardial drainage.The bwi product analysis lab received the device for evaluation on 08-mar-2024.The device evaluation was completed on 13-mar-2024.The product was returned to biosense webster (bwi) for evaluation.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|